Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 14/20 | 0.39 |
| ▸ | DPP8 | Q6V1X1 | 10/20 | 0.39 |
| ▸ | DPP9 | Q86TI2 | 8/20 | 0.39 |
| ▸ | MCHR1 | Q99705 | 5/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.39 |
| ▸ | DPP7 | Q9UHL4 | 7/20 | 0.33 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | FAP | Q12884 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL470902 | 0.93 | DPP4 (0.34) | DPP4DPP8DPP9MCHR1KCNH2 | |
| SCHEMBL470671 | 0.93 | MCHR1 (0.37) | DPP4DPP8DPP9MCHR1KCNH2 | |
| SCHEMBL462540 | 0.92 | DPP4 (0.34) | DPP4DPP8DPP9MCHR1KCNH2 | |
| SCHEMBL12064853 | 0.91 | ALDH1A1 (0.34) | DPP4DPP8DPP9MCHR1KCNH2 | |
| SCHEMBL470636 | 0.90 | MCHR1 (0.37) | DPP4DPP8DPP9MCHR1KCNH2 | |
| SCHEMBL470662 | 0.89 | GPR119 (0.33) | DPP4DPP8DPP9KCNH2DPP7 | |
| SCHEMBL461833 | 0.89 | MCHR1 (0.36) | DPP4DPP8DPP9MCHR1KCNH2 | |
| SCHEMBL12064750 | 0.87 | MCHR1 (0.36) | DPP4DPP8DPP9MCHR1KCNH2 | |
| SCHEMBL470692 | 0.87 | MCHR1 (0.36) | DPP4DPP8DPP9MCHR1KCNH2 | |
| SCHEMBL470624 | 0.86 | GPR119 (0.33) | DPP4DPP8DPP9KCNH2DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011147951-A1 | CYCLOAMINO DERIVATIVES AS GPR119 ANTAGONISTS | PROSIDION LIMITED (GB) | 2011-12-01 | — | — | WO | disclosed |